Alnylam Pharmaceuticals (ALNY) Competitor Comparison
We are evaluating the key criteria listed to compare Alnylam Pharmaceuticals (ALNY) against its competitors in the Biotechnology industry.
Market Capitalization
6 / 368Gross Profits
14 / 278Total Revenue
13 / 300EBITDA
301 / 337Free Cashflow
167 / 352Quick Ratio
263 / 357Earnings per Share
243 / 359Dividend yield
0 / 6Total Cash
7 / 358Performance 3 years
68 / 368Performance 5 years
57 / 368Performance 10 years
47 / 368Linearity 3 years
51 / 368Linearity 5 years
303 / 368Linearity 10 years
331 / 368Total Rank
96 / 368Dividend Rank
343 / 368Valuation Rank
257 / 368Piotroski Rank
113 / 368Muliplier Rank
261 / 368Total Revenue - ALNY ranking 13 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.